Skip to content

Needs Assessment of Cancer Patients With Complementary and Alternative Medicines

Needs Assessment of Cancer Patients With Complementary and Alternative Medicines

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03954509
Acronym
MAC'EVAL
Enrollment
64
Registered
2019-05-17
Start date
2018-07-09
Completion date
2023-04-26
Last updated
2023-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Chemotherapy Effect

Keywords

Complementary and Alternative Medicines

Brief summary

The chronic cancer status, multidisciplinary and ambulatory care, as well as the cumbersome effects of the disease and treatments, lead patients to consider other options than those offered by traditional medicine, such as alternative medicine and complementary (CAM)

Detailed description

In order to put in place a policy on CAM based on the knowledge held by the patient and the health professionals, it is imperative to obtain and analyze the following information: why this type of medicine is used, what are its benefits, how does the patient get information and what are his sources, who practices them and how the patient perceives the place of the hospital and the various health professionals to develop and secure the use of CAM. Our study will focus on CAM that can bring iatrogenic risk (phytotherapy, food supplements, acupuncture, traditional Chinese medicine, homeopathy, essential oils), and the following techniques: hypnosis and sophrology. The study is carried out in two successive phases: the interview phase which will make it possible to obtain results to carry out the questionnaires phase. Patients who will be included in the interview phase will not participate in the questionnaire phase. Finally, patients who participate in the questionnaire phase will not have semi-structured interviews. They will only have to answer the questionnaire.

Interventions

None listed

Sponsors

Hopital Antoine Beclere
CollaboratorOTHER
Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman and man over 18 * Francophone (speaking and reading French) * Patient followed for the management of cancer, hospitalized or not, receiving or having already received a treatment cancer administered orally and / or systemically.

Exclusion criteria

* Patient who has not been treated for cancer with anticancer treatment * Support in a palliative care service * Refusal to participate in the study * Patient under tutorship or curatorship * Patient deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the perception of patients regarding complementary and alternative medicines (CAM) in the management of cancer or its complications but also the place of different health professionals.Time of inclusionThis evaluation is carried out using a semi-directed interview, then a questionnaire

Secondary

MeasureTime frameDescription
Number of factors influencing the consumption of CAMTime of inclusione.g. age, sex, type of cancer, perpeptions of the CAM
Number of iatrogenic risks related to CAM and chemotherapyTime of inclusionCAM used by cancer patients and their chemotherapy
Prevalence of CAM used in cancer patientsTime of inclusionNumber of cancer patients that use CAM
Number of the information sources used by patientsTime of inclusionquestionnaire (eg internet, health professionals, TV)
Identification of the roles of health professionals in the patient's treatment process to help secure information about CAMTime of inclusionquestionnaire (eg health professionals,roles)
Number of the CAM supply sourcesTime of inclusione.g community pharmacies, supermarket, internet)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026